Whole-body MRI may help detect cardiovascular and cerebrovascular changes in patients with diabetes, allowing more aggressive management.
Whole-body MRI can help clinicians assess people with diabetes for increased risk of heart attacks or stroke, according to an article published in the journal Radiology.
Patients with diabetes are at increased risk of developing atherosclerosis, which contributes to major adverse cardiovascular and cerebrovascular events (MACCE), such as heart attack or stroke. By using whole-body MRI, clinicians may be able to identify patients at highest risk for such events and treat or observe them accordingly.
Researchers from Germany studied the predictive value among 65 patients with diabetes with follow-up information available on 61. The patients underwent a contrast-enhanced whole-body MRI protocol, including brain, cardiac, and vascular sequences.
The patients were followed for a median of 5.8 years. Fourteen patients experienced MACCE during this period. The researchers found that patients who had detectable vascular changes faced a cumulative MACCE risk rate of 20 percent at three years and 35 percent at six years. Patients who had normal MRI findings did not experience MACCE.
The researchers acknowledge that more study is needed as using whole-body MRI for such evaluations is relatively new. However, it is advantageous because it can assess patients over larger parts of the body without exposing them to radiation.
“Other established and valuable tools, such as myocardial perfusion imaging or computed tomography (CT) for quantification of coronary calcification, are generally limited to cardiac evaluation due to their associated risk profiles,” said researcher Fabian Bamberg, MD, MPH, in a release. “Also MRI provides unique insights into soft tissue pathology, including cerebral and vascular changes, such as restriction of blood flow to the brain.”
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
New Survey Explores Radiologist and Neurologist Comfort Level with AI Triage for Brain MRI
January 7th 2025Survey results revealed that 71 percent of clinicians preferred adjunctive AI in facilitating triage of brain MRI scans and 58 percent were comfortable utilizing AI triage without input from radiologists.